Honey bee as apitoxin, carries several active components, the most abundant of which is melittin, and the most biologically active are enzymes, particularly phospholipase A2. Bee venom is under laboratory and clinical research for its potential properties and uses in reducing risks for adverse events from bee venom therapy, rheumatoid arthritis, and use as an immunotherapy for protection against allergies from insect stings. Bee venom products are marketed in many countries, but, as of 2018, there are no approved clinical uses for these products which carry various warnings for potential allergic reactions. With an increased number of honey bees in a specific
Toxicology of red imported fire ant venom (LD) on tested female rats is 0.36 mg/kg. Approximately 46 proteins have been identified in the red imported fire ant's venom, although scientists have long believed the venom only contained alkaloids. This assumption was mostly due to the difficulties in obtaining sufficient venom for analysis because of its the low protein content, which is only 0.1% of the venom's total weight. These proteins are experimentally suggested to directly account for the anaphylactic reactions seen in humans sensitive to the venom. Whilst including a number of neurotoxins and potential allergens, not all of these proteins are involved with venom function. At